Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Gilead Sciences Inc (NASDAQ: GILD)


Last Updated: Dec-05-2016 08:25:03

Recent Market News

Today's Gilead Sciences Stock Update

Here's a daily update on the Gilead Sciences stock price for interested investors, plus some key data on GILD stock that's important to know. While we frequently give readers a more detailed Gilead Sciences stock price analysis, you can get a quick rundown of key GILD numbers here, for December 03, 2016.To start, let's look at the Gilead Sciences stock closing price. Shares ended the day's trading session at $72.42. They went down 0.58% or $0.42 from the previous day's close.It's best to not only look at recent Gilead Sciences share data, but also look at the year's highs and lows to see where the current price stacks up...At today's price, GILD is trading below where it was one-year ago, with shares having slipped 30.66%.

TRENDING: The 4 Best Gold Stocks to Buy Now - One's Up 200% in 2016

The Gilead Sciences stock price 52-week high is $104.79. That was hit on 12/17/2015. The GILD stock 52-week low is $71.39, reached on 11/04/2016.And, take note - GILD trading volume yesterday was 8,270,100. That's lower than Gilead Sciences stock's average daily trading volume of 9,227,970.Gilead Sciences's market capitalization - the amount of shares outstanding times the share price - is 95,569,777,000. That gives Gilead Sciences a large market cap, because it's between 10 billion and 200 billion. As of the start of April 2016, Apple has the biggest market cap of all publicly traded companies.

TRENDING: The Best Stocks in the World Are on Sale Now - We Like These 5

The current P/E (price/earnings) ratio of Gilead Sciences stock is 6.15. That's smaller than the March 2016 S&P 500 P/E ratio of about 23. To really gauge if this stock's P/E is high or low, you should compare GILD to other companies in the same industry.The current EPS (earnings per share) of GILD is 10.78.Beta - how closely the stock trades with the overall market, with a beta of 1 meaning it trades in step with the broader index -- for Gilead Sciences is 1.21.Gilead Sciences stock has a dividend yield of 2.55%. Most stocks considered "dividend stocks" have a yield of 2% or more.Every day we publish Gilead Sciences stock news and coverage on a handful of other key stocks we're watching now so you can maximize profits. To get new info and stock news on GILD and other companies you are interested in, sign up for Money Morning - it's free.

UP NEXT: This stock is one of the most promising "double" opportunities on the market today - meaning we expect shares to gain 100% from where they are now. The biggest price catalyst is this company is set to dominate virtual reality. Get it's name and a chance to double your money here.

Click here to read more stories

Premium Research

Gilead Sciences Inc (NASDAQ: GILD) Profile

Volume18,970
Open$72.97
Prior Close$72.42
Market Cap$96.3 B
PE Ratio6.08
Beta1.21
Gilead Sciences Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions for patients and the people who care for them. They have a broad-based focus on developing and marketing drugs to treat patients with infectious diseases including viral infections fungal infections and bacterial infections and a specialized focus on cancer. They have expertise in liposomal drug delivery technology a technology that the company uses to develop drugsthat are safer easier for patients to tolerate and more effective.
SymbolCompanyMarket cap
AMGNAmgen$105.93 B
BIIBBiogen Inc Cmn$64.35 B
REGNRegeneron Pharmaceutical$39.61 B
BXLTBaxalta Incorporated Common Sto$31.46 B
ALXNAlexion Pharm Inc$27.36 B
VRTXVertex Pharmaceutic$19.3 B
INCYIncyte Corporation$18.83 B
BMRNBiomarin Pharmaceut$14.33 B
SGENSeattle Genetics Inc$9.44 B
ALKSAlkermes Plc$8.34 B

GILD Earnings

1st Quarter Earnings$2.75 (2016-11-01)
2nd Quarter Earnings$3.08 (2016-07-25)
3rd Quarter Earnings$3.03 (2016-04-28)
4th Quarter Earnings$3.32 (2016-02-02)
PE Ratio6.08
EPS Growth-10.31%
Recent Earnings$2.75
Annual EPS$11.98
Market Capitalization$96.3 B
Insider Shareholder %0.014%
Annual Revenue$31.58 B
Number of Shares Outstanding1,319,660 Shares
Institutional Shareholder %73.59%
Annual Net Income$15.08B
TTM Net Profit Margin$47.75
One Year Return-28.95%
Three Year Return1.93%
Five Year Return271.06%
Five Year Revenue Growth310.58%
Five Year Earnings Growth607.39%
Five Year Dividend Growth0%
Last Quarter EPS$2.7
Annual EPS$11.98
Annual Dividend$1.88
Annual Dividend Yield2.58%
Change in EPS YTD-10.31%
PE Ratio6.08
Recent Earnings$2.75
Dividends per Share$0.47
Stock Split Ratio2-1
beta1.21

GILD Key Stats

Last Price$72.97
Net Change$0.55 (0.76%)
Bid$72.8
Ask Price$72.97
Open Price$72.97
Previous Close Price$72.42
High Price$72.97
Low Price$72.97
Number of Trades9
Volume18,970
Fifty Two Week High$104.79 (2015-12-17)
Fifty Two Week Low$71.39 (2016-11-04)
Average Daily Volume10,782,129
Share Outstanding1,319,660 Shares
Total Dividend Payout$1.88/yr
Dividend Yield2.58%